European Archives of Psychiatry and Clinical Neuroscience,
Год журнала:
2024,
Номер
unknown
Опубликована: Июль 25, 2024
Abstract
Post-COVID
syndrome
(PCS)
describes
a
persistent
complex
of
symptoms
following
COVID-19
episode,
lasting
at
least
4
to
12
weeks,
depending
on
the
specific
criteria
used
for
its
definition.
It
is
often
associated
with
moderate
severe
impairments
daily
life
and
represents
major
burden
many
people
worldwide.
However,
especially
during
first
two
years
pandemic,
therapeutic
diagnostic
uncertainties
were
prominent
due
novelty
disease
non-specific
definitions
that
overlooked
functional
deficits
lacked
objective
assessment.
The
present
work
comprehensively
examines
status
PCS
as
depicted
in
recent
reviews
meta-analyses,
alongside
exploring
impairments.
We
searched
database
Pubmed
meta-analysis
evaluating
period
between
May
31,
2022,
December
2023.
Out
95
studies,
33
selected
inclusion
our
analyses.
Furthermore,
we
extended
upon
prior
research
by
systematically
recording
linked
identified
studies.
found
fatigue,
neurological
complaints,
exercise
intolerance
most
frequently
reported
symptoms.
In
conclusion,
over
past
eighteen
months,
there
has
been
notable
increase
quantity
quality
studies
PCS.
still
remains
clear
need
improvement,
particularly
regard
definition
necessary
diagnosing
this
syndrome.
Enhancing
aspect
will
render
future
more
comparable
precise,
thereby
advancing
understanding
Microorganisms,
Год журнала:
2023,
Номер
11(12), С. 2959 - 2959
Опубликована: Дек. 11, 2023
The
presence
of
symptoms
after
an
acute
SARS-CoV-2
infection
(long-COVID)
has
become
a
worldwide
healthcare
emergency
but
remains
underestimated
and
undertreated
due
to
lack
recognition
the
condition
knowledge
underlying
mechanisms.
In
fact,
prevalence
post-COVID
ranges
from
50%
during
first
months
up
20%
two-years
after.
This
perspective
review
aimed
map
existing
literature
on
identify
gaps
in
guide
global
effort
toward
improved
understanding
long-COVID
suggest
future
research
directions.
There
is
plethora
symptomatology
that
can
be
COVID-19;
however,
today,
there
no
clear
classification
definition
this
condition,
termed
or
post-COVID-19
condition.
heterogeneity
led
groups/clusters
patients,
which
could
exhibit
different
risk
factors
Viral
persistence,
long-lasting
inflammation,
immune
dysregulation,
autoimmune
reactions,
reactivation
latent
infections,
endothelial
dysfunction
alteration
gut
microbiota
have
been
proposed
as
potential
mechanisms
explaining
complexity
long-COVID.
such
equation,
viral
biology
(e.g.,
re-infections,
variants),
host
genetics,
epigenetics)
external
vaccination)
should
also
considered.
These
various
will
discussed
current
directions
suggested.
Turkish Journal of Physical Medicine and Rehabilitation,
Год журнала:
2023,
Номер
1(1), С. 1 - 7
Опубликована: Фев. 28, 2023
The
worldwide
pandemic
of
coronavirus
disease
2019
(COVID-19)
was
known
to
predominantly
affect
the
lungs,
but
it
realized
that
COVID-19
had
a
large
variety
clinical
involvement.
Cardiovascular,
gastrointestinal,
neurological,
and
musculoskeletal
systems
are
involved
by
direct
or
indirect
mechanisms
with
various
manifestations.
involvement
can
manifest
during
infection,
due
medications
used
for
treatment
COVID-19,
in
post/long
syndrome.
major
symptoms
fatigue,
myalgia/arthralgia,
back
pain,
low
chest
pain.
During
last
two
years,
increased,
no
clear
consensus
obtained
about
pathogenesis.
However,
there
is
valuable
data
supports
hypothesis
angiotensinconverting
enzyme
2,
inflammation,
hypoxia,
muscle
catabolism.
Additionally,
were
also
have
adverse
effects,
such
as
corticosteroid-induced
myopathy
osteoporosis.
Therefore,
while
deciding
drugs,
priorities
benefits
should
be
taken
into
consideration.
Symptoms
begin
three
months
from
onset
continue
at
least
months,
cannot
explained
another
diagnosis
accepted
Prior
may
persist
fluctuate,
new
manifest.
In
addition,
must
one
symptom
infection.
Most
common
myalgia,
arthralgia,
weakness,
sarcopenia,
impaired
exercise
capacity,
physical
performance.
female
sex,
obesity,
elderly
patients,
hospitalization,
prolonged
immobility,
having
mechanical
ventilation,
not
vaccination,
comorbid
disorders
predictors
Musculoskeletal
pain
problem
tends
chronic
form.
There
on
mechanism,
inflammation
angiotensin-converting
2
seem
play
an
important
role.
Localized
generalized
occur
after
general
localized
An
accurate
allows
physicians
initiate
management
proper
rehabilitation
programs.
Nature Communications,
Год журнала:
2024,
Номер
15(1)
Опубликована: Май 18, 2024
Abstract
After
contracting
COVID-19,
a
substantial
number
of
individuals
develop
Post-COVID-Condition,
marked
by
neurologic
symptoms
such
as
cognitive
deficits,
olfactory
dysfunction,
and
fatigue.
Despite
this,
biomarkers
pathophysiological
understandings
this
condition
remain
limited.
Employing
magnetic
resonance
imaging,
we
conduct
comparative
analysis
cerebral
microstructure
among
patients
with
healthy
controls,
that
contracted
COVID-19
without
long-term
symptoms.
We
reveal
widespread
alterations
in
microstructure,
attributed
to
shift
volume
from
neuronal
compartments
free
fluid,
associated
the
severity
initial
infection.
Correlating
these
cognition,
olfaction,
fatigue
unveils
distinct
affected
networks,
which
are
close
anatomical-functional
relationship
respective
International Journal of Molecular Sciences,
Год журнала:
2024,
Номер
25(3), С. 1675 - 1675
Опубликована: Янв. 30, 2024
Patients
suffering
from
chronic
fatigue
syndrome
(CFS)
or
post-COVID
(PCS)
exhibit
a
reduced
physiological
performance
capability.
Impaired
mitochondrial
function
and
morphology
may
play
pivotal
role.
Thus,
we
aimed
to
measure
the
muscle
oxidative
phosphorylation
(OXPHOS)
capacity
assess
in
CFS
PCS
patients
comparison
healthy
controls
(HCs).
Mitochondrial
OXPHOS
was
measured
permeabilized
fibers
using
high-resolution
respirometry.
(subsarcolemmal/intermyofibrillar
form/cristae/diameter/circumference/area)
content
(number
proportion/cell)
were
assessed
via
electron
microscopy.
Analyses
included
differences
between
HC,
CFS,
PCS,
whereas
comparisons
morphology/content
made
for
vs.
PCS.
of
complex
I,
which
compared
HC.
While
subsarcolemmal
area,
volume/cell,
diameter,
perimeter
higher
no
difference
observed
these
variables
intermyofibrillar
mitochondria.
Both
cristae
integrity
CFS.
increased
impaired
function,
but
progressed
pathological
morphological
changes
suggest
structural
due
prolonged
inactivity
unknown
molecular
causes.
Instead,
significantly
lower
I
activity
suggests
probably
direct
virus-induced
alterations.
Brain Behavior and Immunity,
Год журнала:
2024,
Номер
117, С. 510 - 520
Опубликована: Фев. 7, 2024
Cognitive
deficits
are
increasingly
recognized
as
a
long-term
sequela
of
severe
COVID-19.
The
underlying
processes
and
molecular
signatures
associated
with
these
neurological
sequalae
COVID-19
remain
largely
unclear,
but
may
be
related
to
systemic
inflammation-induced
effects
on
the
brain.
We
studied
inflammation-brain
interplay
its
relation
development
cognitive
impairment
in
patients
who
survived
Trajectories
inflammation
neuroaxonal
damage
blood
biomarkers
during
ICU
admission
were
analyzed
outcomes.
Prospective
longitudinal
cohort
study
surviving
admission.
During
admission,
was
sampled
consecutively
assess
levels
inflammatory
cytokines
neurofilament
light
chain
(NfL)
using
an
ultrasensitive
multiplex
Luminex
assay
single
molecule
array
technique
(Simoa).
functioning
evaluated
comprehensive
neuropsychological
assessment
six
months
after
ICU-discharge.
Ninety-six
(median
[IQR]
age
61
[55–69]
years)
enrolled
from
March
2020
June
2021
divided
into
two
cohorts:
those
received
no
COVID-19-related
immunotherapy
(n
=
28)
treated
either
dexamethasone
or
tocilizumab
68).
Plasma
NfL
concentrations
increased
95
%
their
stay,
median
23
[18–38]
pg/mL
at
250
[160–271]
28
days,
p
<
0.001.
Besides
age,
glomerular
filtration
rate,
immunomodulatory
treatment,
C-reactive
protein,
more
specific
markers
day
14
(i.e.,
interleukin
(IL)-8,
tumour
necrosis
factor,
IL-1
receptor
antagonist)
significant
predictors
(R2
44
%,
0.001),
illustrating
association
between
sustained
damage.
Twenty-six
(27
%)
exhibited
discharge
ICU.
showed
pronounced
increase
that
developed
(p
0.03).
Higher
predicted
poorer
outcome
information
processing
speed
(Trail
Making
Test
A,
r
−0.26,
0.01;
Letter
Digit
Substitution
Test,
−0.24,
0.02).
Prolonged
critically
ill
is
subsequent
impairment.
Moreover,
our
findings
suggest
plasma
stay
possess
prognostic
value
predicting
future
European Journal of Public Health,
Год журнала:
2024,
Номер
34(3), С. 489 - 496
Опубликована: Фев. 29, 2024
Abstract
Background
Evidence
on
the
long-term
employment
consequences
of
SARS-CoV-2
infection
is
lacking.
We
used
data
from
a
large,
community-based
sample
in
UK
to
estimate
associations
between
Long
Covid
and
outcomes.
Methods
This
was
an
observational,
longitudinal
study
using
pre–post
design.
included
survey
participants
3
February
2021
30
September
2022
when
they
were
aged
16–64
years
not
education.
Using
conditional
logit
modelling,
we
explored
time-varying
relationship
status
≥12
weeks
after
first
test-confirmed
(reference:
pre-infection)
labour
market
inactivity
(neither
working
nor
looking
for
work)
or
workplace
absence
lasting
≥4
weeks.
Results
Of
206
299
(mean
age
45
years,
54%
female,
92%
white),
15%
ever
inactive
10%
absent
during
follow-up.
Compared
with
pre-infection,
higher
reporting
<40
[adjusted
odds
ratio
(aOR):
1.45;
95%
CI:
1.17–1.81]
40
<52
(aOR:
1.34;
1.05–1.72)
post-infection.
Combining
official
statistics
prevalence,
assuming
correct
statistical
model,
our
estimates
translate
27
000
(95%
6000–47
000)
working-age
adults
being
because
July
2022.
Conclusions
likely
have
contributed
reduced
participation
market,
though
it
unlikely
be
sole
driver.
Further
research
required
quantify
contribution
other
factors,
such
as
indirect
health
effects
pandemic.
Brain Behavior and Immunity,
Год журнала:
2023,
Номер
116, С. 175 - 184
Опубликована: Ноя. 28, 2023
As
the
heterogeneity
of
symptoms
is
increasingly
recognized
among
long-COVID
patients,
it
appears
highly
relevant
to
study
potential
pathophysiological
differences
along
different
subtypes.
Preliminary
evidence
suggests
distinct
alterations
in
brain
structure
and
systemic
inflammatory
patterns
specific
groups
patients.
To
this
end,
we
analyzed
cortical
thickness
peripheral
immune
signature
between
clinical
subgroups
based
on
3
T-MRI
scans
markers
n
=
120
participants
comprising
healthy
never-infected
controls
(n
30),
COVID-19
survivors
29),
patients
with
26)
without
35)
cognitive
impairment
according
screening
Montreal
Cognitive
Assessment.
Whole-brain
comparison
4
was
conducted
by
surface-based
morphometry.
We
identified
areas
showing
a
progressive
increase
across
groups,
starting
from
individuals
who
had
never
been
infected
COVID-19,
followed
survivors,
deficits
(MoCA
≥
26),
finally,
exhibiting
significant
<
26).
These
findings
highlight
continuum
associated
more
pronounced
changes
observed
experiencing
(p
0.05,
FWE-corrected).
Affected
regions
covered
prefrontal
temporal
gyri,
insula,
posterior
cingulate,
parahippocampal
gyrus,
parietal
areas.
Additionally,
discovered
immunophenotype,
elevated
levels
IL-10,
IFNγ,
sTREM2
especially
group
suffering
impairment.
demonstrate
lingering
immunological
impaired
survivors.
This
implies
complex
underlying
pathomechanism
emphasizes
necessity
investigate
whole
spectrum
post-COVID
biology
determine
targeted
treatment
strategies
targeting
sub-groups.
Journal of Clinical Medicine,
Год журнала:
2023,
Номер
12(12), С. 3966 - 3966
Опубликована: Июнь 10, 2023
Post-COVID-19
syndrome
(PCS)
has
been
described
as
'the
pandemic
after
the
pandemic'
with
more
than
65
million
people
worldwide
being
affected.
The
enormous
range
of
symptoms
makes
both
diagnosis
complex
and
treatment
difficult.
In
a
post-COVID
rehabilitation
outpatient
clinic,
184
patients,
mostly
non-hospitalized,
received
comprehensive,
interdisciplinary
diagnostic
assessment
fixed
follow-up
appointments.
At
baseline,
three
in
four
patients
reported
10
symptoms,
most
frequent
were
fatigue
(84.9%),
decreased
physical
capacity
(83.0%),
tiredness
(81.1%),
poor
concentration
(73.6%),
sleeping
problems
(66.7%)
shortness
breath
(67.3%).
Abnormalities
found
mean
values
scores
for
(FAS
=
34.3),
cognition
(MoCA
25.5),
psychological
alterations
(anxiety,
depression,
post-traumatic
stress
disorder),
limitation
lung
function
(CAT)
severity
PCS
(PCFS,
MCRS).
Clinical
abnormalities
elevated
heart
rate,
breathing
rate
at
rest,
blood
pressure
NT-proBNP
levels.
As
frequency
decreases
only
slowly
but
often
significantly
over
course,
it
is
important
to
monitor
longer
period
time.
Many
them
suffer
from
an
immense
symptom
burden,
without
pre-existing
clinical
correlates.
Our
results
show
clear
association
objectifiable
assessments
tests
well
pronounced
symptoms.
Scientific Reports,
Год журнала:
2023,
Номер
13(1)
Опубликована: Июль 12, 2023
Post
coronavirus
disease-19
(post
COVID-19)
is
mainly
studied
in
clinical
populations
and
less
known
about
post
COVID-19
a
young
general
population.
The
aim
of
the
study
to
investigate
prevalence
symptoms
its
potential
risk
factors
adults.
Participants
from
Swedish
population-based
birth
cohort
BAMSE
were
included
(n
=
2022,
mean
age
26.5
years).
was
assessed
through
questionnaire
defined
as
after
confirmed
(registry-based
or
self-reported
positive
test)
lasting
for
≥
2
months.
In
total,
681
participants
had
COVID-19.
Among
them,
112
(16.5%)
fulfilled
definition
(17.8%
females,
14.5%
males,
p
0.26).
most
common
altered
smell
taste
(68.8%),
dyspnea
(33.7%)
fatigue
(30.4%).
Overall,
no
major
identified
except
being
bedbound
during
However,
asthma
rhinitis
associated
with
symptom
dyspnea,
migraine
taste,
lower
self-rated
health
fatigue.
conclusion,
are
common,
also
among
adults
Although
not
life-threatening,
it
could
have
considerable
impact
on
public
due
high
long-term
symptoms.
Frontiers in Immunology,
Год журнала:
2023,
Номер
14
Опубликована: Июль 20, 2023
Background
The
role
of
adaptive
immune
responses
in
long
COVID
remains
poorly
understood,
with
contrasting
hypotheses
suggesting
either
an
insufficient
antiviral
response
or
excessive
associated
inflammatory
damage.
To
address
this
issue,
we
set
to
characterize
humoral
and
CD4+
T
cell
patients
prior
SARS-CoV-2
vaccination.
Methods
Long
who
were
seropositive
(LC+,
n=28)
seronegative
(LC-,
n=23)
by
spike
ELISA
assay
recruited
based
on
(i)
initial
infection
documented
PCR
the
conjunction
three
major
signs
COVID-19
(ii)
persistence
resurgence
at
least
3
symptoms
for
over
months.
They
compared
resolved
(RE,
n=29)
uninfected
control
individuals
(HD,
n=29).
Results
spectrum
persistent
proved
similar
both
groups,
a
trend
higher
number
group
(median=6
vs
4.5;
P=0.01).
use
highly
sensitive
S-flow
enabled
detection
low
levels
spike-specific
IgG
22.7%
ELISA-seronegative
(LC-)
patients.
In
contrast,
uniformly
high
LC+
RE
groups.
Multiplexed
antibody
analyses
30
different
viral
antigens
showed
that
LC-
had
defective
all
proteins
tested
but
most
cases
preserved
other
viruses.
A
primary
line
revealed
detectable
SARS-CoV-2-specific
CD4
39.1%
patients,
while
frequencies
Correlation
overall
strong
associations
between
cellular
responses,
exceptions
group.
Conclusions
These
findings
provide
evidence
two
types
COVID.
Seropositive
coordinated
as
those
recovered
specific
cells
and/or
antibodies
close
half
(52.2%).
divergent
sharing
comparable
raise
possibility
multiple
etiologies